1657-9534

S1657-95342020000200002

10.25100/cm.v51i2.4279

Colombia

00 06 2020

51 2

WHO 2020

2020 19 3 3

149-50

2020 38 1 1

1-9

2015 33

47-51

2015 14 4 4

248-60

2016 164

195-203

2015 14 7 7

475-88

2019 18 1 1

41-58

2004 3 8 8

673-83

O 2017 1 1 1

e87-97

2019 18 1 1

1-2

2016 534 7607 7607

314-6

2017 23 4 4

405-8

2018 175 2 2

168-80

2017 124

74-91

Y 2017 20 5 5

395-402

2016 28 1 1

36-41

2018 32 8 8

747-61

2018 26 10 10

865-76

2019 26 28 28

5363-88

2018 73 2 2

313-22

2016 37 3 3

172-83

2018 94 1 1

40-8

2016 5 10 10

2016 26 9 9

1049-59

2018 175 2 2

223-31

1995 ^sE ^sE E

16-20

2006 2 4 4

411-22

2018 23 3 3

661-72

NIH 2020

2007 2 7 7

944-86

1946 130

1069

2004 323 1 1

264-8

2020 14 1 1

72-3

2014 43 6 6

e167-80

PubChem 2020

2018 27 9 9

1402-3

2020 3 3

1-3

2020 ahead of print ahead of print

2020

105949

H 2020 24

Hsueh P severe acute respiratory syndrome coronavirus 2 and Coronavirus disease-2019 : the epidemic and the challenges 2020 55 3 3

105924

2020 24 1 1

2020

2005 79 10 10

5900-6

2013 31 12 12

1553-9

2006 66

193-292

2020 38 1 1

10-8

2019 70

156-66

2020 Epub ahead of print Epub ahead of print

2020

2020 ahead of print ahead of print

2020

2020 ahead of print ahead of print

2020 367 6485 6485

1412-3

2020 44

2018 391 10133 10133

1927-38

Editor

2020 579

319

2020 395 10233 10233

1322-5

FDA 2020

2001

2016

2010

2020 11 2 2

216-28

ClinicalTrialgov 2020

ClinicalTrial.gov 2020

2020